To prohibit the use of taxpayer dollars to support animal experimentation in the laboratories of adversarial nations.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill prohibits the Department of Health and Human Services (HHS) from using taxpayer money to conduct or fund biomedical research involving animal testing in adversarial nations. The prohibition covers both direct government research and grants/contracts to entities in those countries. Named countries include China (including Hong Kong), Iran, North Korea, and Russia, with authority for HHS to add more.
Who Benefits and How
Domestic research institutions and laboratories benefit as federal research funding that might otherwise flow to foreign competitors will instead stay within the United States. National security interests are served by preventing potential dual-use research from being conducted in adversarial nations. Animal welfare advocates concerned about overseas research standards may view this as a positive restriction.
Who Bears the Burden and How
HHS and NIH face new compliance requirements to ensure no funds flow to prohibited countries. U.S. research institutions with international collaborations involving animal research in named countries must restructure or terminate those partnerships. Pharmaceutical and biotech companies relying on cost-effective overseas animal testing must find alternative arrangements.
Key Provisions
- Prohibits HHS from directly or indirectly conducting animal research in China, Iran, North Korea, or Russia
- Bans federal grants, contracts, and cooperative agreements funding animal research by entities in those countries
- Authorizes HHS Secretary to designate additional foreign countries of concern
- Requires Congressional reporting within 60 days when new countries are designated
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers.
At a Glance
What This Bill Does
Prohibits the use of federal taxpayer dollars to fund or conduct biomedical animal research in adversarial foreign nations including China, Iran, North Korea, and Russia
Key Policy Areas
Health, National Security, Foreign Policy, Research & Development
Primary Purpose
Prohibits the use of federal taxpayer dollars to fund or conduct biomedical animal research in adversarial foreign nations including China, Iran, North Korea, and Russia
Policy Domains
Section 2 - Prohibition on funding research on animals in certain foreign countries
Identified Gains
Contextual inference, no direct clause citation- Domestic biomedical research institutions
- U.S. pharmaceutical companies
- National security interests
Contextual inference, no direct clause citation
Identified Costs
Contextual inference, no direct clause citation- HHS and NIH
- U.S. research institutions with foreign collaborations
- Foreign research facilities in named countries
Contextual inference, no direct clause citation
Sponsors
Joni Ernst
R-IA | Primary Sponsor
Legislative Progress
IntroducedMs. Ernst (for herself and Mr. Schmitt) introduced the following …
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
Contract research organizations (CROs) in adversarial nations, Domestic biomedical research laboratories, U.S. research institutions with foreign animal research collaborations
Positive-direction: Domestic biomedical research laboratories
Negative-direction: Contract research organizations (CROs) in adversarial nations, U.S. research institutions with foreign animal research collaborations
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_secretary"
- → Secretary of Health and Human Services
Key Definitions
Terms defined in this bill
The Committee on Appropriations of the Senate; the Committee on Health, Education, Labor, and Pensions of the Senate; the Committee on Homeland Security and Governmental Affairs of the Senate; the Committee on Appropriations of the House of Representatives; the Committee on Energy and Commerce of the House of Representatives
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology